WWP
CRSP icon

WR Wealth Planners’s CRISPR Therapeutics CRSP Stock Holding History

WR Wealth Planners’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.65K Buy
+42
New +$1.98K ﹤0.01% 879

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WR Wealth Planners's CRSP Position: Q4 2024 in Review

WR Wealth Planners opened a new position in CRISPR Therapeutics (CRSP) in Q4 2024: 42 shares worth $1.65K. The stake represents ﹤0.01% of the portfolio and ranks #879 among its holdings.

404 funds tracked by Wall St. Rank hold CRSP as of Q4 2024.

  • WR Wealth Planners held 42 shares of CRISPR Therapeutics worth $1.65K as of Q4 2024.
  • CRISPR Therapeutics was a new WR Wealth Planners position in Q4 2024.
  • CRISPR Therapeutics made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #879 holding.
  • 404 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.